tiprankstipranks
Advertisement
Advertisement
Altimmune reports 48-week data from IMPACT Phase 2b trial of pemvidutide
PremiumThe FlyAltimmune reports 48-week data from IMPACT Phase 2b trial of pemvidutide
1M ago
Altimmune price target lowered to $20 from $25 at H.C. Wainwright
Premium
The Fly
Altimmune price target lowered to $20 from $25 at H.C. Wainwright
2M ago
Altimmune price target lowered to $11 from $14 at Citizens
Premium
The Fly
Altimmune price target lowered to $11 from $14 at Citizens
2M ago
Altimmune upgraded to Neutral from Sell at Goldman Sachs
PremiumThe FlyAltimmune upgraded to Neutral from Sell at Goldman Sachs
3M ago
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 4/23/2026
Premium
Market News
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 4/23/2026
3M ago
Altimmune 64.25M share Spot Secondary priced at $3.00
Premium
The Fly
Altimmune 64.25M share Spot Secondary priced at $3.00
3M ago
Altimmune initiated with a Buy at Truist
PremiumThe FlyAltimmune initiated with a Buy at Truist
4M ago
Altimmune price target raised to $25 from $12 at H.C. Wainwright
Premium
The Fly
Altimmune price target raised to $25 from $12 at H.C. Wainwright
4M ago
Altimmune, Coherent, Globalstar, Bed Bath & Beyond, Linde Insider Shocks
Premium
Weekend Updates
Altimmune, Coherent, Globalstar, Bed Bath & Beyond, Linde Insider Shocks
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100